findmyKOL
Clinical trialNCT02559960SuspendedObservational

Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study

SponsorZhong WangEnrollment20,000Adverse Drug EventAdverse Drug ReactionAnaphylactic ReactionChinese Medicine
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the People'S Hospital of Zuanjiang District, Chongqing City

    Chongqing, Chongqing Municipality, China

  • the Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Mudanjiang City Second People'S Hospital

    Mudanjiang, Heilongjiang, China

  • People'S Hospital of Jun County

    Hebi, Henan, China

  • People'S Hospital of Changge City

    Xuchang, Henan, China

  • the First Hospital of Henan College of Traditional Chinese Medicine

    Zhengzhou, Henan, China

  • the Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China

  • Zhengzhou Second Hospital

    Zhengzhou, Henan, China

  • Shandong Energy Zaozhuang Mining Group Center Hospital

    Zaozhuang, Shandong, China

  • Zaozhuang Hospital of T.C.M

    Zaozhuang, Shandong, China

  • Shanxi Provincial Hospital of Traditional Chinese Medicine

    Taiyuan, Shanxi, China

  • Changzheng Hospital of Tianjin City

    Tianjin, Tianjin Municipality, China

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China

  • First Affilicated Hospital of Kunming Medical University

    Kunming, Yunnan, China

  • the Red Cross Hosptal of Yunnan

    Kunming, Yunnan, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2015
Primary completion
31 Aug 2021
Completion
31 Dec 2021
Last update posted
8 Apr 2021
Registered enrollment
20,000
Registry id
NCT02559960

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.